These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 366978)

  • 41. Urinary cross-linked fibrin degradation products in glomerular disease with crescents.
    Kamitsuji H; Matsunaga K; Taira K; Nakajima M; Whitworth JA; Kincaid-Smith P
    Clin Nephrol; 1988 Mar; 29(3):124-8. PubMed ID: 3359703
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Fibrin and fibrinogen degradation products in the urine of patients with nephrotic syndrome].
    Ena IaM
    Sov Med; 1975 Jul; (7):85-9. PubMed ID: 1216058
    [No Abstract]   [Full Text] [Related]  

  • 43. [ Products of fibrin degradation in the urine during experimental and human glomerulonephritis].
    Lagrue G; Hirbec G; Gouault-Heilmann M; Levent M; Branellec A; Moisy M
    Pathol Biol (Paris); 1975 Jun; 23(6):486-91. PubMed ID: 1105353
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Urinary fibrin/fibrinogen degradation products (FDP) in chronic glomerulonephritis].
    Shimamatsu K
    Fukuoka Igaku Zasshi; 1986 Sep; 77(9):480-9. PubMed ID: 3804170
    [No Abstract]   [Full Text] [Related]  

  • 45. Urinary FDP, heterophile agglutinins IgG, IgM, and C3 in renal homotransplant rejection and glomerulonephritis.
    Anderton JL; Hoq MS; Clarkson AR; Cash JD
    Proc Eur Dial Transplant Assoc; 1973; 10(0):500-7. PubMed ID: 4607330
    [No Abstract]   [Full Text] [Related]  

  • 46. [Determination of fibrin and fibrinogen split products by their anticoagulant activity].
    Belitser VA; Varetskaia TV; Tsynkalovskaia SN; Tsariuk LA; Shevchenko LI
    Ukr Biokhim Zh; 1976; 48(4):521-32. PubMed ID: 982623
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of de novo membranous glomerulonephritis on the clinical course after kidney transplantation.
    Schwarz A; Krause PH; Offermann G; Keller F
    Transplantation; 1994 Sep; 58(6):650-4. PubMed ID: 7940683
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Components of kallikrein-kinin system in the urine of patients with glomerulonephritis].
    Paskhina TS; Poliantseva LR; Platonova LV; Levina GO
    Vopr Med Khim; 1990; 36(4):62-9. PubMed ID: 2173275
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical significance of urinary fibrin/fibrinogen degradation products in renal disease. Second report: Urinary fibrin/fibrinogen degradation products in nephrotic syndrome. (author' transl)].
    Miyamura S
    Nihon Jinzo Gakkai Shi; 1978 Apr; 20(4):315-26. PubMed ID: 671855
    [No Abstract]   [Full Text] [Related]  

  • 50. [Loss of 2 kidney grafts due to recurrence of type II membrano-proliferative glomerulonephritis].
    Leumann EP; Briner J; Fierz W; Largiadèr F
    Schweiz Med Wochenschr; 1980 Mar; 110(11):408-13. PubMed ID: 6988957
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urinary fibrin/fibrinogen derivatives.
    Hedner U
    Thromb Diath Haemorrh; 1975 Dec; 34(3):693-708. PubMed ID: 54945
    [No Abstract]   [Full Text] [Related]  

  • 52. [Determination of fibrin fibrinogen degradation products in urine after kidney allotransplantation].
    Drannik GN; Ena IaM; Glukhen'kaia ZE
    Lab Delo; 1978; (5):266-71. PubMed ID: 79008
    [No Abstract]   [Full Text] [Related]  

  • 53. [Monitoring of interleukin-8 in urine and in serum of patients after kidney transplantation].
    Boratyńska M
    Przegl Lek; 1998; 55(11):576-80. PubMed ID: 10216370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proteinuria and nephrotic syndrome associated with chronic rejection of kidney transplants.
    Harlan WR; Holden KR; Williams GM; Hume DM
    N Engl J Med; 1967 Oct; 277(15):769-76. PubMed ID: 4167288
    [No Abstract]   [Full Text] [Related]  

  • 55. ["De novo" glomerulonephritis in the transplanted kidney].
    Stefanov G; Beleva B; Simeonov P; Minkova V; Anastasov G
    Vutr Boles; 1989; 28(2):85-7. PubMed ID: 2669343
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical importance of determination of the products of decomposition of fibrin and fibrinogen in urine in patients with glomerulonephritis].
    Belitskaia GA; Ena IaM; Varetskaia TV; Tsynkalevskaia SN; Tsariuk LA
    Ter Arkh; 1975; 47(4):46-50. PubMed ID: 1145480
    [No Abstract]   [Full Text] [Related]  

  • 57. [Trypsin inhibitor in the urine of patients with glomerulonephritis].
    Paskhina TS; Platonova LV; Poliantseva LR
    Vopr Med Khim; 1988; 34(1):89-94. PubMed ID: 3369132
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urinary fibrin/fibrinogen degradation products measured using an anti-fibrinogen antibody predict orthostatic proteinuria.
    Kanai H; Sawanobori E; Kobayashi A; Goto M; Higashida K; Sugita K
    Pediatr Int; 2018 Jul; 60(7):639-644. PubMed ID: 29654610
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A new and sensitive method to detect acute rejection in renal transplantation.
    Kano T; Orihara A; Morozumi K; Uchida K; Yamada N; Tominaga Y; Kawai M; Takagi H
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1691-4. PubMed ID: 3547877
    [No Abstract]   [Full Text] [Related]  

  • 60. Transplant nephrectomy and simultaneous second graft retransplantation.
    Lurie A; Pfeffermann R; Butt K; Kountz SL
    Isr J Med Sci; 1976 Jan; 12(1):16-20. PubMed ID: 767295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.